Literature DB >> 12471544

Complications of endoscopic sphincterotomy: results from a single tertiary referral center.

M Barthet1, N Lesavre, A Desjeux, M Gasmi, P Berthezene, S Berdah, X Viviand, J C Grimaud.   

Abstract

BACKGROUND AND STUDY AIMS: Complications of endoscopic sphincterotomy (ES) have been assessed in recent multicenter studies. The aim of this series was to report and identify risk factors for complications of ES at a single tertiary referral center. PATIENTS AND METHODS: Between 1996 and 2000, 1159 consecutive endoscopic retrograde cholangiopancreatographies (ERCP) procedures were performed and their related complications were assessed. A total of 658 patients (57 %) underwent ES. All the clinical, radiological and biological data were carefully recorded within the 30 days following the procedure. Multivariate analysis was performed using a stepwise logistic model.
RESULTS: The morbidity rate for ES was 7.7 %, being moderate to severe in 5 %. Morbidity included acute pancreatitis (3.5 %), perforations (1.8 %), sepsis (1.2 %) and bleeding (1.2 %). The 30-day mortality was 0.9 %. In the 1159 ERCP procedures, 231 patients underwent precut papillotomy (20 %) followed by sphincterotomy in 174 cases. Using logistic regression analysis, the risk factors for ES were precut papillotomy (relative risk, RR 2.76), confidence interval, (CI 1.39 - 5.49) and the presence of sphincter of Oddi dysfunction (RR, 7.72, CI 3.2 - 18.4).
CONCLUSIONS: In this single-center series, we found a complication rate of ES in about 7 %, comparable to that in multicenter series. Precut papillotomy and sphincter of Oddi dysfunction were the main independent risk factors for ES.

Entities:  

Mesh:

Year:  2002        PMID: 12471544     DOI: 10.1055/s-2002-35834

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  32 in total

1.  The burden of endoscopic retrograde cholangiopancreatography (ERCP) performed with the patient under conscious sedation.

Authors:  S M Jeurnink; E W Steyerberg; E J Kuipers; P D Siersema
Journal:  Surg Endosc       Date:  2012-08       Impact factor: 4.584

2.  Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.

Authors:  Ryan D Madanick; Colm J O'Loughlin; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

3.  Partially covered vs uncovered sphincterotome and post-endoscopic sphincterotomy bleeding.

Authors:  Panagiotis Katsinelos; George Paroutoglou; Jannis Kountouras; Grigoris Chatzimavroudis; Christos Zavos; Sotiris Terzoudis; Taxiarchis Katsinelos; Kostas Fasoulas; George Gelas; George Tzovaras; Ioannis Pilpilidis
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

4.  Severe and fatal complications after ERCP: analysis of 2555 procedures in a single experienced center.

Authors:  P Salminen; S Laine; R Gullichsen
Journal:  Surg Endosc       Date:  2007-12-20       Impact factor: 4.584

5.  Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Zahra Taherzadeh; Homayoon Sokhanvar; Tolou Hasandokht
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

6.  Endoscopic ultrasound-guided biliary drainage: a review.

Authors:  Shannon Melissa Chan; Anthony Yuen Bun Teoh
Journal:  Curr Treat Options Gastroenterol       Date:  2015-06

7.  Use of a pancreatic duct stent or guidewire facilitates bile duct access with low rates of precut sphincterotomy: a randomized clinical trial.

Authors:  Gregory A Coté; Daniel K Mullady; Sreenivasa S Jonnalagadda; Rajesh N Keswani; Sachin B Wani; Christine E Hovis; Tarek Ammar; Abed Al-Lehibi; Steven A Edmundowicz; Sri Komanduri; Riad R Azar
Journal:  Dig Dis Sci       Date:  2012-06-26       Impact factor: 3.199

8.  Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them.

Authors:  Nicholas M Szary; Firas H Al-Kawas
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

9.  Optimal time of resuming anticoagulant after endoscopic sphincterotomy in patients at risk for thromboembolism: a retrospective cohort study.

Authors:  Woo Hyun Paik; Sang Hyub Lee; Dong Won Ahn; Ji Bong Jeong; Jin Woo Kang; Jun Hyuk Son; Ji Kon Ryu; Yong-Tae Kim
Journal:  Surg Endosc       Date:  2018-03-06       Impact factor: 4.584

10.  Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats.

Authors:  Emma Folch-Puy; Susana Granell; Juan L Iovanna; Marc Barthet; Daniel Closa
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.